Biomaterials
IBEC has a wide expertise in designing, fabricating and characterizing biomaterials for use in biological and health applications, in particular regenerative therapies. We put emphasis both in the study of … Read more
Search Results for:
Nanomaterials
IBEC has specialized expertise in designing nanoparticle-based therapies encompassing fabrication, characterization, functionalization, behavior modeling, and in vivo/in vitro testing. Focus Areas:
@ beautyinscience February 23th
Last week I showed a teaser of my video. Far from being finished, it was meant to share a current state of my work and to get into the mood … Read more
#cell_culture&一═デ︻ ρσѕтнυмαηιѕм ︻デ═一.
My initial interest was in the historical and fictional exploration of the techniques made possible by working in cell culture lab. The possibility of cultivating living matter outside the body, … Read more
Científics de l’IBEC i ISGlobal desenvolupen un compost innovador eficaç contra malària i la leishmaniosi
Un estudi liderat per l’IBEC i ISGlobal ha demostrat el potencial antileishmanial d’un compost antimalàric. Dissenyat inicialment per a la malària, aquest fàrmac mostra una elevada eficàcia contra la leishmaniosi, marcant un avenç únic i prometedor per al tractament d’ambdues infeccions.
IBEC Seminar: Kevin Braeckmans
Delivering effector molecules in cells in vitro and ex vivo by photoporation. Kevin Braeckmans, Biophotonics Research Group, Lab. General Biochemistry and Physical Pharmacy, Ghent University, Belgium Delivery of bioactive compounds, … Read more
Nanomedicina per fer front a les malalties rares
Experts en Nanomedicina de diferents camps s’han reunit avui per cinquè any consecutiu al Nano Rare Diseases Day. Es tracta d’un esdeveniment coorganitzat per la plataforma NANOMED Spain, coordinada per l’IBEC, i l’Hospital Sant Joan de Déu, on s’exposen els últims avenços en nanomedicina per al diagnòstic i el tractament de les malalties minoritàries.
Postdoctoral Researcher at the Cellular and Molecular Mechanobiology Research Group
Ref: PR_PR // Deadline: 13/03/2024